ライフサイエンスコーパス: serovar

1 vealed at least 13 well segregated variants (serovars).

2 thods lack resolution for this highly clonal serovar.

3 solates were distributed among 188 different serovars.

4 the principal reservoirs of many pathogenic serovars.

5 y both nontyphoidal and typhoidal Salmonella serovars.

6 intestinal infections, compared to other NTS serovars.

7 gainst homologous and heterologous Chlamydia serovars.

8 uld likely protect against only one or a few serovars.

9 ped a new multiplex PCR for the detection of serovars 1 to 3, 5 to 8, 10, and 12 along with apxIV, th

10 ed a single serovar and 20 grew 2 Salmonella serovars, 1 being NTS.

11 and a PCR was formulated that differentiated serovar 16 isolates from all 15 known serovars and other

12 used whole-genome sequencing of the proposed serovar 16 reference strain A-85/14 to confirm the prese

13 existence of a sixteenth serovar-designated serovar 16-of A. pleuropneumoniae.

14 t forward that they comprised a new serovar, serovar 16.

15 PCR, using redesigned primers targeting the serovar 3 capsule locus, which differentiates serovars 3

16 The new primers eliminate an aberrant serovar 3-indicative amplicon found in some serovar 6 cl

17 erovar 3 capsule locus, which differentiates serovars 3, 6, and 8 Actinobacillus pleuropneumoniae iso

18 erence strain with the exception of those in serovars 5 and 12, which are identical in terms of gene

19 fied between serovars, with the exception of serovars 5 and 12.

20 serovar 3-indicative amplicon found in some serovar 6 clinical isolates.

21 that the previously unsequenced S. enterica serovar 9,12:l,v:- belongs to the B clade of Salmonella

22 Four serovars accounted for 87% of the 687 NTS isolates, incl

23 cally within both typhoidal and nontyphoidal serovars, although the SrgE protein sequences found with

24 lates and showed the best ability to predict serovars among the subtyping methods tested.

25 ined from 667 children; 667 yielded a single serovar and 20 grew 2 Salmonella serovars, 1 being NTS.

26 ghly lethal challenge dose of the homologous serovar and determined protection against other group B

27 e of the software in querying for a pathogen serovar and for genome sequence identifiers.

28 Multidrug resistance has emerged in all 3 serovars and is seen in the overwhelming majority of iso

29 tiated serovar 16 isolates from all 15 known serovars and other common respiratory pathogenic/commens

30 s is found sporadically throughout different serovars, and several inhibit activation of the innate i

31 ritidis, and 3% (3) were Salmonella enterica serovar Arizonae.

32 ulator TviA, which is absent from Salmonella serovars associated with human gastroenteritis, represse

33 ighly conserved across different S. enterica serovars, but residue 161, located close to the catalyti

34 Both serovars can adhere to and invade M cells and enterocyte

35 Human infection with typhoidal Salmonella serovars causes a febrile systemic disease, termed enter

36 mined protection against other group B and D serovars circulating in sub-Saharan Africa.

37 tradermal (i.d.) challenge by L. interrogans serovar Copenhageni strain Fiocruz L1-130 in Golden Syri

38 Leptospira interrogans serovar Copenhageni transmitted from Rattus norvegicus t

39 of C3H/HeJ mice with Leptospira interrogans serovar Copenhageni using an enzootic mode of transmissi

40 han age 10 weeks with Leptospira interrogans serovar Copenhageni.

41 be applied to humans, we used C. trachomatis serovar D (strain UW-3/Cx) to induce infertility in mice

42 oculations of rhesus macaques with wild-type serovar D strain D/UW-3/Cx or a plasmid-deficient deriva

43 nant MOMP (rMOMP) from Chlamydia trachomatis serovars D (UW-3/Cx), E (Bour), or F (IC-Cal-3) or Chlam

44 ecovered from mice immunized with rMOMP from serovars D, E, and F were 0.38 x 10(6), 7.56 x 10(6), an

45 he conserved LNPTIAG epitope and neutralized serovars D, E, and F.

46 and their surrounding constant segments from serovars D, E, and F.

47 gical data show the existence of a sixteenth serovar-designated serovar 16-of A. pleuropneumoniae.

48 inst the group D serovar Salmonella enterica serovar Dublin (85% vaccine efficacy).

49 were decidualised in-vitro, infected with Ct serovar E, and changes in expression of genes of interes

50 omparative genomic analysis reveals that all serovars encode a subset of "core" effectors, suggesting

51 on in different hosts, including S. enterica serovar Enteritidis (multiple hosts), S. Gallinarum (bir

52 Salmonella enterica serovar Enteritidis (S. Enteritidis) is a major etiologi

53 ovar Typhimurium SpvD having an arginine and serovar Enteritidis a glycine at this position.

54 es of S. Typhimurium and Salmonella enterica serovar Enteritidis DeltaguaBA DeltaclpX live oral vacci

55 ological surveillance of Salmonella enterica serovar Enteritidis for over 2 decades.

56 Salmonella enterica serovar Enteritidis is a significant cause of gastrointe

57 c of Salmonella enterica subspecies enterica serovar Enteritidis phage type (PT) 4, which peaked in 1

58 cted a large outbreak of Salmonella enterica serovar Enteritidis phage type 14b affecting more than 3

59 phimurium, 10% (10) were Salmonella enterica serovar Enteritidis, and 3% (3) were Salmonella enterica

60 ogical paradox surrounds Salmonella enterica serovar Enteritidis.

61 Salmonella enterica serovars Enteritidis and Kentucky differ greatly in epid

62 ic, and asymptomatic colonizers of chickens, serovars Enteritidis, Heidelberg, and Kentucky.

63 stinguished between all previously described serovars except 5 and 12, which were detected by the sam

64 ng (MLST) was able to accurately predict the serovars for 42/46 isolates and showed the best ability

65 isolation of Salmonella of a wide variety of serovars, from an array of animal feeds, food animals, a

66 e the two invasive avian-adapted S. enterica serovar Gallinarum biotypes Gallinarum and Pullorum, and

67 s of ceftiofur-resistant Salmonella enterica serovar Heidelberg in Quebec and Ontario attributable to

68 sults of 2 patients, each infected only with serovar Ia strains, revealed multiple same-serovar infec

69 o investigate the distribution of Salmonella serovars in MCL and their products, a total of 1287 pre-

70 h serovar Ia strains, revealed multiple same-serovar infections over 1-5 years.

71 The age distribution and limited serovars involved make control of NTS disease by vaccine

72 characterization of this locus among the 15 serovars is the first step in understanding the genetic,

73 oenteritis-producing nontyphoidal Salmonella serovars, is a potent inhibitor of T-cell activation.

74 175) and compared with strains from the same serovars isolated from human clinical cases, livestock,

75 Serovar J strains isolated from 1 patient 3 years apart

76 d caspase-inducing, wild-type C. trachomatis serovar L2 led to infertility, but the noninflammation-i

77 ranuloma venereum isolate of C. trachomatis, serovar L2, with either the original shuttle vector (pGF

78 ntamination in the food supply, a minimum of serovar level differentiation is required.

79 Four NTS serovars (Mbandaka, Bredeney, Infantis and Virchow) were

80 , Gram-negative bacteria Salmonella enterica serovar Montevideo.

81 ) in attenuating infectivity across multiple serovars of C. trachomatis without host cell toxicity.

82 variation within the capsule loci of the 15 serovars of H. parasuis, for rapid molecular serotyping.

83 enabling the differentiation of 14 of the 15 serovars of H. parasuis.

84 Serovars of Salmonella enterica cause both gastrointesti

85 Serovars of Salmonella enterica, namely Typhi and Typhim

86 Two major serovars of Salmonella enterica, Typhi and Typhimurium,

87 onses in poultry to infections with distinct serovars of Salmonella enterica.

88 resistance in 135 typhoidal and nontyphoidal serovars of Salmonella.

89 spira-nonresponsive cells, bound to multiple serovars of two Leptospira species, L. borgpetersenii, a

90 is a relatively new species name for certain serovars of Ureaplasma urealyticum, and PCR is useful fo

91 s able to distinguish among eight Salmonella serovars on a microcantilever.

92 ca serovar Typhi, whereas 86% (131/152) were serovars other than Typhi (nontyphoidal Salmonella).

93 uals were shown to be infected with a single serovar over a lengthy period.

94 e fatality (27.8%) was higher than for other serovars (P = .0009).

95 s with RDAS derived from Salmonella enterica serovar Paratyphi A and Salmonella enterica serovar Typh

96 human challenge model of Salmonella enterica serovar Paratyphi A infection.

97 Salmonella enterica serovar Paratyphi A is a human-specific serovar that, to

98 Salmonella enterica serovar Paratyphi A is a major cause of enteric fever, w

99 i or Salmonella enterica subspecies enterica serovar Paratyphi A or C were only isolated in 14 (0.03%

100 by infections with drug-resistant S enterica serovar Paratyphi A.

101 and the expression of SPI-1 in the typhoidal serovarS Paratyphi A compared to that of the nontyphoida

102 e chronic shedding of Leptospira interrogans serovar Pomona in California sea lions (Zalophus califor

103 were identified, with three dogs having two serovars present.

104 uter membrane protein (MOMP) to elicit cross-serovar protection, groups of mice were immunized by the

105 abolically with most, if not all, Salmonella serovars, representing a novel approach to control of th

106 o the epidemiology and genomics of prevalent serovars, responsible for recurring illness.

107 nce of any association between load and age, serovar, risk of transmission, hormone levels, and concu

108 CVD 1944 protected mice against the group D serovar Salmonella enterica serovar Dublin (85% vaccine

109 CVD 1931 protected mice against the group B serovar Salmonella enterica serovar Stanleyville (91% va

110 ed immunosensor to know the concentration of serovar Salmonella typhimurium.

111 sing infectious bacteria Salmonella enterica serovar (Salmonella typhi) in 10 muL of sample volume.

112 terica serovar Typhi and Salmonella enterica serovar Sendai, causes enteric fever.

113 with Salmonella enterica subspecies enterica serovar Senftenberg are often associated with exposure t

114 Salmonella enterica serovar Senftenberg is a common nontyphoidal Salmonella

115 al was put forward that they comprised a new serovar, serovar 16.

116 Salmonella serovars sidestep the competition by using their virulen

117 -translational modifications (PTM), identify serovar specific markers, and validate genomic predicted

118 ation of proteins that result from expressed serovar specific nonsynonymous SNPs.

119 the first time we show that reproducible and serovar specific systemic biomarkers can be detected dur

120 onstruct promoted strong immune responses to serovar-specific epitopes, the conserved LNPTIAG epitope

121 genetic, molecular, and structural bases of serovar specificity in this poorly studied but important

122 inst the group B serovar Salmonella enterica serovar Stanleyville (91% vaccine efficacy), and S. Ente

123 separately from those found in nontyphoidal serovars, suggesting functional diversification.

124 rgE protein sequences found within typhoidal serovars tend to cluster separately from those found in

125 rica serovar Paratyphi A is a human-specific serovar that, together with Salmonella enterica serovar

126 Serovars that are uncommonly associated with human disea

127 There are over 2,600 serovars that cause a range of disease manifestations ra

128 Additionally, salmonella serovars that cause human infection can change over time

129 ubiquitous species contains more than 2,600 serovars that may differ in their host specificity, clin

130 this new niche support a bloom of Salmonella serovars, thereby ensuring transmission of the pathogen

131 ion of typhoidal and nontyphoidal Salmonella serovars to invasive disease varies considerably in plac

132 sia, multidrug-resistant Salmonella enterica serovar Typhi (S Typhi) has been the main cause of enter

133 luence susceptibility to Salmonella enterica serovar Typhi (S Typhi) infection.

134 Salmonella enterica serovar Typhi (S Typhi) is responsible for an estimated

135 Salmonella enterica serovar Typhi (S. Typhi) differs from most other salmone

136 quence analysis of 1,832 Salmonella enterica serovar Typhi (S. Typhi) identifies a single dominant MD

137 The population of Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid

138 ovar that, together with Salmonella enterica serovar Typhi and Salmonella enterica serovar Sendai, ca

139 roarray containing 2,724 Salmonella enterica serovar Typhi antigens (>63% of proteome) and identified

140 Salmonella enterica serovar Typhi causes the systemic disease typhoid fever.

141 Multiyear epidemics of Salmonella enterica serovar Typhi have been reported from countries across e

142 bcontinent, with chronic Salmonella enterica serovar Typhi infection reported as a significant risk f

143 Salmonella enterica serovar Typhi is a human-restricted Gram-negative bacter

144 Salmonella enterica serovar Typhi is associated with a disseminated febrile

145 Salmonella enterica serovar Typhi is the etiological agent of typhoid fever.

146 yphoid fever case with a Salmonella enterica serovar Typhi isolate showing extended spectrum beta-lac

147 systemic infection with Salmonella enterica serovar Typhi or Paratyphi pathovars A, B or C(1).

148 Salmonella enterica subspecies enterica serovar Typhi or Salmonella enterica subspecies enterica

149 e used a live attenuated Salmonella enterica serovar Typhi strain to create a bivalent mucosal plague

150 ed a Salmonella enterica subspecies enterica serovar Typhi strain with resistance against beta-lactam

151 serovar Paratyphi A and Salmonella enterica serovar Typhi to induce protective immunity against bact

152 ctamase (ESBL)-producing Salmonella enterica serovar Typhi was identified, whole-genome sequence type

153 binding sites were identified in S. enterica serovar Typhi, 22 of which were associated with OmpR-reg

154 Salmonella enterica and Salmonella enterica serovar Typhi, and Yersinia pestis), and 3 protozoa (Lei

155 Mycobacterium leprae and Salmonella enterica serovar Typhi, but the function of parkin in immunity ha

156 agent of typhoid fever, Salmonella enterica serovar Typhi, can partially subvert this critical innat

157 Enteric fever, caused by Salmonella enterica serovar Typhi, is an important public health problem in

158 Salmonella enterica serovar Typhi, the causative agent of typhoid fever in h

159 Salmonella enterica serovar Typhi, the cause of typhoid, is host restricted

160 ellae, 14% (21/152) were Salmonella enterica serovar Typhi, whereas 86% (131/152) were serovars other

161 , with a predominance of Salmonella enterica serovar Typhi.

162 mophilus influenzae, and Salmonella enterica serovar Typhi/Typhimurium.

163 enteric fever caused by Salmonella enterica serovars Typhi and Paratyphi is substantial and has high

164 degrees C-42 degrees C) Salmonella enterica serovars Typhi, Paratyphi A, and Sendai significantly at

165 were Salmonella enterica subspecies enterica serovar Typhimurium (45% [116/258] of which were multilo

166 FrmR from Salmonella enterica serovar typhimurium (a CsoR/RcnR-like transcriptional de

167 sinia enterocolitica and Salmonella enterica serovar Typhimurium (all gram-negative bacteria) and Sta

168 ed melibiose permease of Salmonella enterica serovar Typhimurium (MelBSt) demonstrates that MelB is a

169 araginase II produced by Salmonella enterica serovar Typhimurium (S Typhimurium) inhibits T cell resp

170 istant to infection with Salmonella enterica serovar Typhimurium (S Typhimurium).

171 Salmonella enterica serovar Typhimurium (S.

172 steria monocytogenes and Salmonella enterica serovar Typhimurium (S.

173 Salmonella enterica serovar Typhimurium (S. typhimurium) is a leading cause

174 Salmonella enterica serovar Typhimurium (S. Typhimurium) pathogenicity islan

175 rtant foodborne pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) simultaneously acti

176 ere that Salmonella enterica subsp. enterica serovar Typhimurium (S. Typhimurium) uses d-glucosaminat

177 t the enteric bacterium, Salmonella enterica serovar Typhimurium (S. Typhimurium), is a vacuolar path

178 es of mice infected with Salmonella enterica serovar Typhimurium (S. Typhimurium).

179 Salmonella enterica serovar Typhimurium (ST) sense Toll-like receptor (TLR)-

180 igated in the context of Salmonella enterica serovar Typhimurium (ST).

181 by the enteric pathogens Salmonella enterica serovar Typhimurium and Citrobacter rodentium.

182 urli fibers, produced by Salmonella enterica serovar Typhimurium and Escherichia coli.

183 acteriophage P22 infects Salmonella enterica serovar Typhimurium and is a model for icosahedral viral

184 pathogens that use T3SS, Salmonella enterica serovar Typhimurium and Yersinia pseudotuberculosis.

185 tion is proposed for the Salmonella enterica serovar Typhimurium ArnT.

186 lular bacterial pathogen Salmonella enterica serovar Typhimurium as shown by their superior containme

187 d the vT3SS and fT3SS of Salmonella enterica serovar Typhimurium at ~5 and ~4 nm resolution using ele

188 The food-borne pathogen Salmonella enterica serovar Typhimurium benefits from acute inflammation in

189 Salmonella enterica serovar Typhimurium can inject effector proteins into ho

190 Conversely, Salmonella enterica serovar Typhimurium causes gastroenteritis in humans and

191 med typhoid fever, while Salmonella enterica serovar Typhimurium causes localized gastroenteritis in

192 intracellular bacterium Salmonella enterica serovar Typhimurium causes persistent systemic inflammat

193 We observed enhanced Salmonella enterica serovar Typhimurium colonization in the intestinal epith

194 reduced ability to kill Salmonella enterica serovar Typhimurium compared to that of macrophages isol

195 The ST313 pathovar of Salmonella enterica serovar Typhimurium contributes to a high burden of inva

196 lso demonstrate that the Salmonella enterica serovar Typhimurium core promoter is more active than pr

197 inflammatory response induced by Salmonella serovar Typhimurium creates a favorable niche for this g

198 ane vesicles (OMVs) from Salmonella enterica serovar Typhimurium displaying the variable N terminus o

199 ination of two prevalent Salmonella enterica serovar Typhimurium DT104 clones in Israel, which are ge

200 t colonization niche for Salmonella enterica serovar Typhimurium during gastrointestinal infections.

201 that Salmonella enterica subspecies enterica serovar Typhimurium employs a dedicated mechanism, drive

202 ng in this locus in FQ-resistant S. enterica serovar Typhimurium epidemic clones resulted in the same

203 recent study showed that Salmonella enterica serovar Typhimurium exhibits sliding motility under magn

204 Salmonella enterica serovar Typhimurium exploits the host's type I interfero

205 IS) to screen mutants of Salmonella enterica serovar Typhimurium for their ability to infect and grow

206 ative bacterial pathogen Salmonella enterica serovar Typhimurium from macrophages.

207 sis of core genes within Salmonella enterica serovar Typhimurium genomes reveals a high degree of all

208 ase and a chitinase from Salmonella enterica serovar Typhimurium hydrolyze LacNAc from Galbeta1-4GlcN

209 entrations, inhibits E. coli and S. enterica serovar Typhimurium in an additive or antagonistic manne

210 in cells in vitro and increased virulence of serovar Typhimurium in mice.

211 pathway and promote virulence of S. enterica serovar Typhimurium in mice.

212 found that intracellular Salmonella enterica serovar Typhimurium induced the binucleation of a large

213 pathogen and host during Salmonella enterica serovar Typhimurium infection and reveal the molecular i

214 Salmonella enterica serovar Typhimurium infection of immunocompetent mice re

215 RD9 is suppressed during Salmonella enterica serovar Typhimurium infection, facilitating increased IL

216 Salmonella enterica serovar Typhimurium is a bacterial pathogen causing gast

217 Salmonella enterica serovar Typhimurium is a common cause of food-borne gast

218 Salmonella enterica serovar Typhimurium is a food-borne pathogen that causes

219 Salmonella enterica serovar Typhimurium is a Gram-negative food-borne pathog

220 Salmonella enterica serovar Typhimurium is an enteropathogen that causes sel

221 ate immune resistance of Salmonella enterica serovar Typhimurium is attributed to the high-molecular-

222 n efflux transporters in Salmonella enterica serovar Typhimurium is discussed in the context of cellu

223 c mechanism of FrmR from Salmonella enterica serovar Typhimurium is triggered by metals in vitro, and

224 locus sequence typing on Salmonella enterica serovar Typhimurium isolates was performed.

225 op model inoculated with Salmonella enterica serovar Typhimurium LPS.

226 re absent in the closely related S. enterica serovar Typhimurium LT2 and from a mutant of S Montevide

227 The genome of Salmonella enterica serovar Typhimurium LT2 encodes 26 GNATs, 11 of which ha

228 U microcompartments from Salmonella enterica serovar Typhimurium LT2 that were imaged previously.

229 li K12, E. coli O157:H7, Salmonella enterica serovar Typhimurium LT2, Staphylococcus aureus, and Stre

230 s initially found on the Salmonella enetrica serovar Typhimurium multi-resistance plasmid pMG101 from

231 ompetent, but avirulent, Salmonella enterica serovar Typhimurium mutant for its ability to compete wi

232 ture of the prototypical Salmonella enterica serovar Typhimurium pathogenicity island 1 basal body, d

233 entify most of the 3,838 Salmonella enterica serovar Typhimurium promoters in just two RNA-seq runs.

234 viA gene in nontyphoidal Salmonella enterica serovar Typhimurium reduced flagellin-induced pyroptosis

235 teropathogenic bacterium Salmonella enterica serovar Typhimurium requires a T6SS encoded within Salmo

236 e intracellular pathogen Salmonella enterica serovar Typhimurium requires the mgtC gene to cause dise

237 se to the catalytic triad, is variable, with serovar Typhimurium SpvD having an arginine and serovar

238 t the genomes of S. enterica subsp. enterica serovar Typhimurium strain LT2 and Salmonella bongori st

239 genetically engineered a Salmonella enterica serovar Typhimurium strain of multilocus sequence type 3

240 cterium tuberculosis, in Salmonella enterica serovar Typhimurium strain SL3261.

241 ostatic activity against Salmonella enterica serovar Typhimurium that is not shared by the related pu

242 rdinates the response of Salmonella enterica serovar Typhimurium to diverse environmental challenges

243 examined the ability of Salmonella enterica serovar Typhimurium to infect the central nervous system

244 e CspA family members of Salmonella enterica serovar Typhimurium to link the constitutively expressed

245 ur) in the resistance of Salmonella enterica serovar Typhimurium to the reactive nitrogen species pro

246 as an orthologue of the Salmonella enterica serovar Typhimurium type III secretion system chaperone,

247 Conversely, Salmonella enterica serovar Typhimurium uses a T3SS encoded by Salmonella pa

248 the intestinal pathogen Salmonella enterica serovar Typhimurium uses specialized metal transporters

249 Salmonella enterica serovar Typhimurium utilizes molecular hydrogen as a sub

250 tween FlgM and FliS from Salmonella enterica serovar Typhimurium was characterized using gel shift, i

251 rimentally infected with Salmonella enterica serovar Typhimurium was investigated.

252 ria monocytogenes V7 and Salmonella enterica serovar Typhimurium were used as model pathogens to eval

253 plore the interaction of Salmonella enterica serovar Typhimurium with iHOs.

254 in the PhoPQ regulon of Salmonella enterica serovar Typhimurium with that of PhoPQ-regulated horizon

255 Salmonella (Salmonella enterica serovar Typhimurium) secrete numerous effector proteins,

256 ia (Escherichia coli and Salmonella enterica serovar Typhimurium).

257 isolates, 40% (41) were Salmonella enterica serovar Typhimurium, 10% (10) were Salmonella enterica s

258 Salmonella enterica serovar Typhimurium, an intracellular pathogen, activate

259 almonellae, particularly Salmonella enterica serovar Typhimurium, are a major cause of invasive disea

260 uman and animal pathogen Salmonella enterica serovar Typhimurium, biofilm formation is correlated wit

261 Klebsiella pneumoniae or Salmonella enterica serovar Typhimurium, enhanced translocation.

262 In Salmonella enterica serovar Typhimurium, flagella-mediated motility is repre

263 bic peptide expressed in Salmonella enterica serovar Typhimurium, inhibits growth in macrophages thro

264 In Salmonella enterica serovar Typhimurium, Mg(2+) limitation induces transcrip

265 herichia coli (EHEC) and Salmonella enterica serovar Typhimurium, or the surrogate murine infection m

266 r bacteria, specifically Salmonella enterica serovar Typhimurium, Pectobacterium carotovorum and Legi

267 aps of Escherichia coli, Salmonella enterica serovar Typhimurium, Pseudomonas aeruginosa, Bacillus su

268 in Escherichia coli and Salmonella enterica serovar Typhimurium, suggesting that CyaY and YggX might

269 Unlike the nontyphoidal Salmonella enterica serovar Typhimurium, the genomes of S. Typhi and S. Para

270 al functions, strains of Salmonella enterica serovar Typhimurium, the murine model of S Typhi, in whi

271 III protein secretion in Salmonella enterica serovar Typhimurium, we discovered that several TCMs can

272 reus and Salmonella enterica subsp. enterica serovar Typhimurium, were exposed to 25 kGy gamma radiat

273 2+) channel gene corA in Salmonella enterica serovar Typhimurium, which was previously thought to be

274 an efficiently attenuate Salmonella enterica serovar Typhimurium-induced pyroptosis and proinflammato

275 e intracellular pathogen Salmonella enterica serovar Typhimurium.

276 or upon coinfection with Salmonella enterica serovar Typhimurium.

277 nd the invasive pathogen Salmonella enterica serovar Typhimurium.

278 d virulence functions in Salmonella enterica serovar Typhimurium.

279 to hydrogen peroxide in Salmonella enterica serovar Typhimurium.

280 during colitis caused by Salmonella enterica serovar Typhimurium.

281 a Citrobacter koseri and Salmonella enterica serovar typhimurium.

282 es of the model pathogen Salmonella enterica serovar Typhimurium.

283 and aerobic expansion of Salmonella enterica serovar Typhimurium.

284 Mice were infected with Salmonella enterica serovar typhimurium; cecum and small-intestine tissues w

285 ella (NTS), particularly Salmonella enterica serovars Typhimurium and Enteritidis, is responsible for

286 typhi A compared to that of the nontyphoidal serovarS Typhimurium.

287 raction was done from Salmonella typhimurium serovars, under the optimized growth conditions for its

288 th the winning metabolic strategy Salmonella serovars use to edge out competing microbes in the infla

289 uation of the ability to identify Salmonella serovars using (i) different molecular subtyping methods

290 nvasive NTS from whom 1 of the 4 predominant serovars was isolated in pure culture, 448 (81.0%) were

291 al for Salmonella spp., which include >2,600 serovars, we performed an initial evaluation of the abil

292 A capsule locus and in silico serovar were identified for all but two nontypeable isol

293 istinct from the previously characterized 15 serovars were described, and a proposal was put forward

294 ic techniques speciated isolates; Salmonella serovars were determined.

295 In the 67 isolates, 27 unique serovars were identified, with three dogs having two ser

296 ons (1.2%) and nontyphoidal Salmonella (NTS) serovars were isolated 10,139 times (6.1%), of which 801

297 ontrolling virulence phenotypes in typhoidal serovars, which is likely to play a role in the distinct

298 association of nontyphoidal Salmonella (NTS) serovars with invasive infections, 48,345 Salmonella cas

299 o serotype this bacterium, distinguishing 15 serovars with some nontypeable isolates.

300 ant genetic variation was identified between serovars, with the exception of serovars 5 and 12.